Tension-Type Headache
Investigational use with small case series suggesting frequency reduction in chronic tension headache via reduction of pericranial muscle tension and venous congestion.
Patient Summary
- Is this FDA-cleared for this use?
- Not FDA-cleared for tension-type headache. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, 2004). Use for tension headache is investigational.
- What evidence exists?
- Tier C (investigational). One small uncontrolled case series (Michalsen 2003, n=18) reported headache-frequency reduction after 3 sessions over 6 weeks. There are no randomized controlled trials. Headache trials are highly susceptible to placebo response. First-line treatments — tricyclics (amitriptyline), behavioral therapy, postural and ergonomic correction, biofeedback, physiotherapy — remain standard of care.
- Main risks
- Bleeding from bite sites for 6 to 24 hours after leech detachment
- Bruising and tenderness over the trapezius, occiput, and temples for 3 to 7 days
- Itching and irritation at bite sites for days to weeks
- Local skin infection or, rarely, Aeromonas infection from leech gut bacteria
- Allergic reaction to leech saliva (uncommon)
- Temporary worsening of headache or neck pain for 1 to 2 days
- Small permanent scars at bite sites
- Who should not consider this
- Patients taking blood thinners (warfarin INR >2.0, apixaban, rivaroxaban, dabigatran, heparin)
- Patients with hemophilia or other bleeding disorders
- Patients with severe anemia (Hb <10 g/dL)
- Patients with a weakened immune system
- Patients with active medication-overuse headache (taper analgesics first)
- Patients with secondary headache (rule out structural/infectious cause first)
- What to ask your clinician
- Have I had medication-overuse headache and secondary causes ruled out?
- Have I completed an adequate trial of amitriptyline, physical therapy, biofeedback, and ergonomic correction?
- What evidence supports leech therapy for tension headache specifically?
- What is the practitioner's experience and Aeromonas-prevention plan?
- What is the realistic chance of benefit, given the tiny published evidence base?
- What is the cost, and what does it commit me to?
- When to seek urgent care
- New or progressive neurologic symptoms — weakness, numbness, speech difficulty, vision change
- Sudden worst headache of life (call 911)
- Headache with fever, neck stiffness, or confusion
- Bleeding from bite sites lasting more than 24 to 48 hours
- Spreading redness, warmth, pus, or red streaks at bite sites
- Fever above 38.0 C / 100.4 F or chills
- Hives, throat tightness, or breathing difficulty
What this does NOT mean
- This is not FDA-cleared for tension-type headache.
- A single 18-patient uncontrolled series is not evidence of efficacy in the general population.
- Mechanism rationale (muscle decongestion, anti-inflammatory peptides) does NOT establish clinical efficacy.
- Leech therapy does not address underlying drivers (medication overuse, postural, psychological).
- Reported benefit in a small series does not predict your individual response.
Safety cross-references
Clinical Profile
- Category
- neurological
- ICD-10
- G44.209, G44.219, G44.229
- Safety tier
- low
Evidence Summary
No controlled trial or clinical case series of leech therapy for tension-type headache has been published, and PubMed indexes no clinical evidence for this indication. A proposed mechanism (reduction of pericranial muscle tension via local anti-inflammatory salivary peptides plus venous decongestion) is plausible but untested. The evidence base is insufficient to recommend leech therapy over conventional management (tricyclics, biofeedback, physiotherapy); medication-overuse headache should be excluded before any adjunctive use is considered, and use remains investigational.
Treatment specifics
How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: switch the audience selector in the top bar to “Clinician” to view protocol detail.)
Key Trials
- Michalsen A (2003), n=18
Contraindications
- Active anticoagulant therapy (warfarin INR >2.0, DOACs, heparin)
- Hemophilia or other bleeding disorder
- Severe anemia (Hb <10 g/dL)
- Active bacteremia or sepsis
- Known hypersensitivity to leech salivary proteins
- Pregnancy (relative — first/third trimester)
- Immunocompromised state with severe neutropenia
- Medication-overuse headache (taper analgesics first)
Related Conditions
Cervical Radiculopathy
Off-label use with one RCT (Michalsen 2018) showing significant pain reduction at 7 days in cervical radiculopathy without surgical indication.
Lumbar Radiculopathy (Sciatica)
Off-label use with controlled trial evidence (n=80) showing leg pain and Oswestry score improvement at 4-12 weeks in non-surgical lumbar disc disease.
Migraine
Investigational use with case-series evidence for reduction of migraine frequency and intensity; mechanism plausible via reduction of cervico-cranial venous congestion.
Sciatica (Non-Discogenic / Piriformis)
Investigational use for non-discogenic sciatica including piriformis syndrome; case-series evidence for pain reduction.